A major negative consequence in cancer survivors is chronic pain. The estimates are variable, but reports suggest that prevalence of pain in cancer survivors is as high as 40%. It is dependent on the type and invasiveness of the tumor, the treatment approach used, time since cancer treatment, and the effectiveness of initial pain therapy. The current guidelines by American Society of Clinical Oncology suggest recommendations to manage pain in cancer survivor patients.
There are many guidelines available for management of acute pain or pain associated with advanced disease. There aren’t many studies done to address the issue of long-term safety and effectiveness of interventions to manage chronic pain in cancer patients who survive the disease. Prescribing opioids has been widely accepted as a drug of choice for acute pain or pain associated with advanced disease but there is no broad…
